List of Tables
Table 1. Global Single-target Anti-VEGF Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Single-target Anti-VEGF Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Single-target Anti-VEGF Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Single-target Anti-VEGF Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Single-target Anti-VEGF Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Single-target Anti-VEGF Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Single-target Anti-VEGF Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Single-target Anti-VEGF Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Single-target Anti-VEGF Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Single-target Anti-VEGF Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Single-target Anti-VEGF Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Single-target Anti-VEGF Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Single-target Anti-VEGF Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Single-target Anti-VEGF Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Single-target Anti-VEGF Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Single-target Anti-VEGF Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Single-target Anti-VEGF Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Single-target Anti-VEGF Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Single-target Anti-VEGF Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Single-target Anti-VEGF Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Single-target Anti-VEGF Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Single-target Anti-VEGF Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Single-target Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Single-target Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Single-target Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Single-target Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Single-target Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Single-target Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Single-target Anti-VEGF Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Single-target Anti-VEGF Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Single-target Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Single-target Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Single-target Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Single-target Anti-VEGF Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Single-target Anti-VEGF Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Single-target Anti-VEGF Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Single-target Anti-VEGF Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Single-target Anti-VEGF Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Single-target Anti-VEGF Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Single-target Anti-VEGF Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Single-target Anti-VEGF Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Single-target Anti-VEGF Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Single-target Anti-VEGF Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Single-target Anti-VEGF Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Single-target Anti-VEGF Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Single-target Anti-VEGF Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Single-target Anti-VEGF Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Single-target Anti-VEGF Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis Single-target Anti-VEGF Drugs Product
Table 79. Novartis Recent Developments/Updates
Table 80. Coherus BioSciences Company Information
Table 81. Coherus BioSciences Description and Business Overview
Table 82. Coherus BioSciences Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Coherus BioSciences Single-target Anti-VEGF Drugs Product
Table 84. Coherus BioSciences Recent Developments/Updates
Table 85. Regeneron Pharmaceuticals Company Information
Table 86. Regeneron Pharmaceuticals Description and Business Overview
Table 87. Regeneron Pharmaceuticals Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Regeneron Pharmaceuticals Single-target Anti-VEGF Drugs Product
Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
Table 90. Samsung Bioepis Company Information
Table 91. Samsung Bioepis Description and Business Overview
Table 92. Samsung Bioepis Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Samsung Bioepis Single-target Anti-VEGF Drugs Product
Table 94. Samsung Bioepis Recent Developments/Updates
Table 95. Biocon Biologics Company Information
Table 96. Biocon Biologics Description and Business Overview
Table 97. Biocon Biologics Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Biocon Biologics Single-target Anti-VEGF Drugs Product
Table 99. Biocon Biologics Recent Developments/Updates
Table 100. Chengdu Kanghong Pharmaceutical Company Information
Table 101. Chengdu Kanghong Pharmaceutical Description and Business Overview
Table 102. Chengdu Kanghong Pharmaceutical Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Chengdu Kanghong Pharmaceutical Single-target Anti-VEGF Drugs Product
Table 104. Chengdu Kanghong Pharmaceutical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Single-target Anti-VEGF Drugs Distributors List
Table 108. Single-target Anti-VEGF Drugs Customers List
Table 109. Single-target Anti-VEGF Drugs Market Trends
Table 110. Single-target Anti-VEGF Drugs Market Drivers
Table 111. Single-target Anti-VEGF Drugs Market Challenges
Table 112. Single-target Anti-VEGF Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Single-target Anti-VEGF Drugs
Figure 2. Global Single-target Anti-VEGF Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Single-target Anti-VEGF Drugs Market Share by Type: 2025 & 2032
Figure 4. Aflibercept Product Picture
Figure 5. Conbercept Product Picture
Figure 6. Ranibizumab Product Picture
Figure 7. Brolucizumab Product Picture
Figure 8. Faricimab Product Picture
Figure 9. Other Product Picture
Figure 10. Global Single-target Anti-VEGF Drugs Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Single-target Anti-VEGF Drugs Market Share by Application: 2025 & 2032
Figure 12. Age-related Macular Degeneration
Figure 13. Diabetic Retinopathy
Figure 14. Other
Figure 15. Global Single-target Anti-VEGF Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Single-target Anti-VEGF Drugs Market Size (US$ Million), 2021–2032
Figure 17. Global Single-target Anti-VEGF Drugs Sales (K Units), 2021–2032
Figure 18. Global Single-target Anti-VEGF Drugs Average Price (US$/Unit), 2021–2032
Figure 19. Single-target Anti-VEGF Drugs Report Years Considered
Figure 20. Single-target Anti-VEGF Drugs Sales Share by Manufacturers in 2025
Figure 21. Global Single-target Anti-VEGF Drugs Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Single-target Anti-VEGF Drugs Players: Market Share by Revenue in Single-target Anti-VEGF Drugs in 2025
Figure 23. Single-target Anti-VEGF Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Single-target Anti-VEGF Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Single-target Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 26. North America Single-target Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 27. United States Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Single-target Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 30. Europe Single-target Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 31. Germany Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Single-target Anti-VEGF Drugs Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Single-target Anti-VEGF Drugs Revenue Market Share by Region (2021–2032)
Figure 38. China Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Single-target Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 46. Latin America Single-target Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Single-target Anti-VEGF Drugs Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Single-target Anti-VEGF Drugs Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Single-target Anti-VEGF Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Single-target Anti-VEGF Drugs by Type (2021–2032)
Figure 57. Global Revenue Market Share of Single-target Anti-VEGF Drugs by Type (2021–2032)
Figure 58. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Single-target Anti-VEGF Drugs by Application (2021–2032)
Figure 60. Global Revenue Market Share of Single-target Anti-VEGF Drugs by Application (2021–2032)
Figure 61. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Application (2021–2032)
Figure 62. Single-target Anti-VEGF Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
